Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Upcoming Events

Calendar Review
JCCC Research Seminar Featuring Dr. Guido Eibl
Obesity, Inflammation and Pancreatic Cancer
Date: 5/23/2013
Time: 12:00 PM - 1:00 PM
Cost: Free
Location: 73-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095

JCCC SeminarDr. Guido Eibl

Presented by:
Guido Eibl, M.D.
Associate Professor, Department of Surgery
Director of Surgical Research, Division of General Surgery
Director, NCI Program Project on Diet-Induced Pancreatic Cancer
Member of the Signal Transduction and Therapeutics Program Area

Dr. Guido Eibl studies the role of cyclooxygenase enzymes in pancreatic cancer. Cyclooxygenases convert certain fatty acids to biologically active products called prostaglandins, which have a variety of effects on cancer cells. They can stimulate pancreatic cancer growth and spread and increase the resistance to chemotherapeutic agents. Inhibiting the production of prostaglandins is therefore a promising therapeutic approach in pancreatic cancer.

Light lunch served

Sponsored by the JCCC Signal Transduction and Therapeutics Program Area